| Title |
Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
|
|---|---|
| Published in |
Cancer Management and Research, June 2022
|
| DOI | 10.2147/cmar.s363568 |
| Pubmed ID | |
| Authors |
Cong Shi, Shengping Gong, An Wu, Tingting Niu, Ningning Wu, Yi Zhang, Guifang Ouyang, Qitian Mu |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2022.
All research outputs
#2,415,494
of 25,584,565 outputs
Outputs from Cancer Management and Research
#53
of 2,067 outputs
Outputs of similar age
#52,755
of 447,543 outputs
Outputs of similar age from Cancer Management and Research
#1
of 44 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,067 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,543 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.